Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Yvette Drew.

Newcastle AuthorsTitleYearFull text
Dr Yvette Drew
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 102023
Hannah Smith
Dr Elaine Willmore
Dr Asima Mukhopadhyay
Dr Yvette Drew
Professor Nicola Curtin
et al.		Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling2022
Alice Bradbury
Professor Nicola Curtin
Dr Yvette Drew
The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response2022
Victoria Chamberlain
Dr Yvette Drew
Professor John Lunec
Tipping growth inhibition into apoptosis by combining treatment with MDM2 and WIP1 inhibitors in p53WT uterine leiomyosarcoma2022